Literature DB >> 11081814

Development of myasthenia gravis in a patient with multiple sclerosis during treatment with glatiramer acetate.

A Frese, F Bethke, P Lüdemann, F Stögbauer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11081814     DOI： 10.1007/s004150070118

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  8 in total

1.  Glatiramer acetate induced acute exacerbation of autoimmune hepatitis in a patient with multiple sclerosis.

Authors:  Helmut Neumann; Antal Csepregi; Michael Sailer; Peter Malfertheiner
Journal:  J Neurol       Date:  2007-03-12       Impact factor: 4.849

2.  Myasthenia gravis following alemtuzumab therapy for multiple sclerosis.

Authors:  Luciana Midaglia; Margarida Gratacòs; Edoardo Caronna; Nuria Raguer; Jaume Sastre-Garriga; Xavier Montalban; Mar Tintoré
Journal:  Neurology       Date:  2018-08-24       Impact factor: 9.910

3.  Risk-benefit assessment of glatiramer acetate in multiple sclerosis.

Authors:  T Ziemssen; O Neuhaus; R Hohlfeld
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

4.  Clinical characteristics of autoimmune disorders in the central nervous system associated with myasthenia gravis.

Authors:  Kimitoshi Kimura; Yoichiro Okada; Chihiro Fujii; Kenichi Komatsu; Ryosuke Takahashi; Sadayuki Matsumoto; Takayuki Kondo
Journal:  J Neurol       Date:  2019-07-24       Impact factor: 4.849

5.  Glatiramer acetate-induced acute hepatotoxicity in an adolescent with MS.

Authors:  Naila Makhani; Bo-yee Ngan; Binita M Kamath; E Ann Yeh
Journal:  Neurology       Date:  2013-07-24       Impact factor: 9.910

6.  Primary progressive multiple sclerosis and generalized myasthenia gravis: an uncommon association.

Authors:  G Bigliardi; J Mandrioli; F Valzania; P Nichelli; N Casula; A M Simone; P Sola
Journal:  Neurol Sci       Date:  2010-06-29       Impact factor: 3.307

7.  Acute hepatitis induced by glatiramer acetate.

Authors:  Pierre Deltenre; Marie-Odile Peny; André Dufour; Mohamed El Nady; Jean Henrion
Journal:  BMJ Case Rep       Date:  2009-02-27

Review 8.  Regulatory T cells in multiple sclerosis and myasthenia gravis.

Authors:  K M Danikowski; S Jayaraman; B S Prabhakar
Journal:  J Neuroinflammation       Date:  2017-06-09       Impact factor: 8.322
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.